Collectively, these data show that IGF blockade is unlikely to affect CD8+ T cells priming, does not affect CD8+ T cell survival or proliferation within the PDAC TME and that their increased accumulation in tumours must be attributed to other factors affecting different steps of the CI cycle. Here, IGF1 is linked to neoplasm.